Bicycle therapeutics to participate in the 23rd annual needham virtual healthcare conference

Cambridge, england & boston--(business wire)--bicycle therapeutics plc (nasdaq: bcyc), a biopharmaceutical company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (bicycle®) technology, today announced that management will participate in a fireside chat at the 23rd annual needham virtual healthcare conference on april 9, 2024, at 11 a.m. et. a live webcast of the fireside chat will be accessible from the investor section of the company's websi.
BCYC Ratings Summary
BCYC Quant Ranking